{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:06:27Z","timestamp":1792699587917,"version":"4.5.0"},"reference-count":33,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.6910-25","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:12:17Z","timestamp":1777327937000},"source":"Crossref","is-referenced-by-count":2,"title":["The Predictive Value of the Substantia Nigra and Locus Coeruleus Volumes Using 3D Neuromelanin-sensitive MRI to Predict the Outcomes after Deep Brain Stimulation in Advanced Parkinson's Disease: An Exploratory Study"],"prefix":"10.2169","author":[{"given":"Ai","family":"Hanawa","sequence":"first","affiliation":[{"name":"School of Medicine, Mie University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Matsuura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Mie University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kajikawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Mie University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Department of Dementia Prevention and Therapeutics, Mie University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Mie University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaya","family":"Utsunomiya","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Mie University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Miyashita","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Mie University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kagawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Suzuka Kaisei Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Ii","sequence":"additional","affiliation":[{"name":"Department of Neuroimaging and Pathophysiology, Mie University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Wakita","sequence":"additional","affiliation":[{"name":"Department of Brain Function and Therapeutics, School of Medicine, Mie University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Shindo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Mie University, Japan"},{"name":"Department of Dementia Prevention and Therapeutics, Mie University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord 30: 1591-1601, 2015.","DOI":"10.1002\/mds.26424"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Matsuura K, Maeda M, Yata K, et al. Neuromelanin magnetic resonance imaging in Parkinson's disease and multiple system atrophy. Eur Neurol 70: 70-77, 2013.","DOI":"10.1159\/000350291"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Matsuura K, Ii Y, Maeda M, et al. Neuromelanin-sensitive magnetic resonance imaging in disease differentiation for parkinsonism or neurodegenerative disease affecting the basal ganglia. Parkinsonism Relat Disord 87: 75-81, 2021.","DOI":"10.1016\/j.parkreldis.2021.05.002"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Sasaki M, Shibata E, Tohyama K, et al. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Neuroreport 17: 1215-1218, 2006.","DOI":"10.1097\/01.wnr.0000227984.84927.a7"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Oustwani CS, Korutz AW, Lester MS, Kianirad Y, Simuni T, Hijaz TA. Can loss of the swallow tail sign help distinguish between Parkinson Disease and the Parkinson-Plus syndromes? Clin Imaging 44: 66-69, 2017.","DOI":"10.1016\/j.clinimag.2017.04.005"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Pyatigorskaya N, Magnin B, Mongin M, et al. Comparative Study of MRI Biomarkers in the Substantia Nigra to Discriminate Idiopathic Parkinson Disease. AJNR Am J Neuroradiol 39: 1460-1467, 2018.","DOI":"10.3174\/ajnr.A5702"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kashihara K, Shinya T, Higaki F. Reduction of neuromelanin-positive nigral volume in patients with MSA, PSP and CBD. Intern Med 50: 1683-1687, 2011.","DOI":"10.2169\/internalmedicine.50.5101"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Matsuura K, Kajikawa H, Tabei KI, et al. The effectiveness of istradefylline for the treatment of gait deficits and sleepiness in patients with Parkinson's disease. Neurosci Lett 662: 158-161, 2018.","DOI":"10.1016\/j.neulet.2017.10.018"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hatano T, Okuzumi A, Kamagata K, et al. Neuromelanin MRI is useful for monitoring motor complications in Parkinson's and PARK2 disease. J Neural Transm (Vienna) 124: 407-415, 2017.","DOI":"10.1007\/s00702-017-1688-9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Garcia-Lorenzo D, Longo-Dos Santos C, Ewenczyk C, et al. The coeruleus\/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease. Brain 136 (Pt 7): 2120-2129, 2013.","DOI":"10.1093\/brain\/awt152"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Fischbach F, Muller M, Bruhn H. Magnetic resonance imaging of the cranial nerves in the posterior fossa: a comparative study of t2-weighted spin-echo sequences at 1.5 and 3.0 tesla. Acta Radiol 49: 358-363, 2008.","DOI":"10.1080\/02841850701824127"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hwang KS, Langley J, Tripathi R, Hu XP, Huddleston DE. In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson's disease using neuromelanin-sensitive MRI: Replication in two cohorts. PLoS One 18: e0282684, 2023.","DOI":"10.1371\/journal.pone.0282684"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Lozano AM, Lipsman N, Bergman H, et al. Deep brain stimulation: current challenges and future directions. Nat Rev Neurol 15: 148-160, 2019.","DOI":"10.1038\/s41582-018-0128-2"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Bronstein JM, Tagliati M, Alterman RL, et al. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol 68: 165, 2011.","DOI":"10.1001\/archneurol.2010.260"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Welter ML, Houeto JL, Tezenas du Montcel S, et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain 125 (Pt 3): 575-583, 2002.","DOI":"10.1093\/brain\/awf050"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Matsuura K, Maeda M, Tabei KI, et al. A longitudinal study of neuromelanin-sensitive magnetic resonance imaging in Parkinson's disease. Neurosci Lett 633: 112-117, 2016.","DOI":"10.1016\/j.neulet.2016.09.011"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Beach PA, Hyland S, Chen X, Huddleston DE. Locus coeruleus degeneration is associated with orthostatic hypotension in Parkinson's disease and multiple system atrophy. Clin Auton Res 2025.","DOI":"10.1007\/s10286-025-01164-2"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Nakajima A, Shimo Y, Sekimoto S, et al. Dopamine transporter imaging predicts motor responsiveness to levodopa challenge in patients with Parkinson's disease: A pilot study of DATSCAN for subthalamic deep brain stimulation. J Neurol Sci 385: 134-139, 2018.","DOI":"10.1016\/j.jns.2017.12.030"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lee SH, Kim M, Lee J, et al. Clinical factors and dopamine transporter availability for the prediction of outcomes after globus pallidus deep brain stimulation in Parkinson's disease. Sci Rep 12: 16870, 2022.","DOI":"10.1038\/s41598-022-19150-3"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ghaedian T, Razmkon A, Kalhor L, et al. Correlation of response to subthalamic deep brain stimulation in Parkinson's disease patients with striatal dopamine transporter density on 99mtc-TRODAT-1 SPECT. Neurol Res 45: 505-509, 2023.","DOI":"10.1080\/01616412.2022.2162219"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Zhou Y, Zhang Y, Li G, Zhang W. Neuromelanin-sensitive MRI as a biomarker for individualized deep brain stimulation in Parkinson's disease: Associations between substantia nigra imaging and therapeutic outcomes. Parkinsonism Relat Disord 144: 108205, 2026.","DOI":"10.1016\/j.parkreldis.2026.108205"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Tanaka M, Aihara Y, Ikeda S, Aihara Y. [Neuromelanin-related contrast in the substantia nigra semiquantitatively evaluated by magnetic resonance imaging at 3T: comparison between normal aging and Parkinson disease]. Rinsho Shinkeigaku 51: 14-20, 2011.","DOI":"10.5692\/clinicalneurol.51.14"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Matsuda H, Murata M, Mukai Y, et al. Japanese multicenter database of healthy controls for [(123)I]FP-CIT SPECT. Eur J Nucl Med Mol Imaging 45: 1405-1416, 2018.","DOI":"10.1007\/s00259-018-3976-5"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kashihara K, Kondo T, Mizuno Y, et al. Official Japanese Version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale: validation against the original English version. Mov Disord Clin Pract 1: 200-212, 2014.","DOI":"10.1002\/mdc3.12058"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Nilsson MH, Hariz GM, Wictorin K, Miller M, Forsgren L, Hagell P. Development and testing of a self administered version of the Freezing of Gait Questionnaire. BMC Neurol 10: 85, 2010.","DOI":"10.1186\/1471-2377-10-85"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Jost ST, Kaldenbach MA, Antonini A, et al. Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals. Mov Disord 38: 1236-1252, 2023.","DOI":"10.1002\/mds.29410"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Usher M, Cohen JD, Servan-Schreiber D, Rajkowski J, Aston-Jones G. The role of locus coeruleus in the regulation of cognitive performance. Science 283: 549-554, 1999.","DOI":"10.1126\/science.283.5401.549"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Sara SJ. The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci 10: 211-223, 2009.","DOI":"10.1038\/nrn2573"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Sun H, Gan C, Cao X, et al. Microstructural and functional abnormalities of the locus coeruleus in freezing of gait in Parkinson's disease. Neurobiol Dis 208: 106868, 2025.","DOI":"10.1016\/j.nbd.2025.106868"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Seo S, Yoon YJ, Lee S, et al. Striatal dopamine transporter uptake predicts neuronal hypometabolism and visuospatial function in Parkinson's disease. Eur J Nucl Med Mol Imaging 52: 2307-2316, 2025.","DOI":"10.1007\/s00259-025-07137-x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Vriend C, van Balkom TD, van Druningen C, et al. Processing speed is related to striatal dopamine transporter availability in Parkinson's disease. Neuroimage Clin 26: 102257, 2020.","DOI":"10.1016\/j.nicl.2020.102257"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Gargano A, Olabiyi BF, Palmisano M, Zimmer A, Bilkei-Gorzo A. Possible role of locus coeruleus neuronal loss in age-related memory and attention deficits. Front Neurosci 17: 1264253, 2023.","DOI":"10.3389\/fnins.2023.1264253"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Costa KM. The effects of aging on substantia nigra dopamine neurons. J Neurosci 34: 15133-15134, 2014.","DOI":"10.1523\/JNEUROSCI.3739-14.2014"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_6910-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:21:36Z","timestamp":1777692096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_6910-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":33,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6910-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"6910-25"}}